Mar 15, 2018 - Phillips 66 has created value.Five Below is an accelerating business.Eli Lilly and Abbott Labs over Merck & Co.
Mar 15, 2018 - Consider these three stocks in the rapidly-growing diabetes devices market for grand returns.
Mar 12, 2018 - HeartMate 3 performed better in clinical test than Abbott’s older device.
Mar 12, 2018 - It's dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios. Without rehashing the wild r
Mar 11, 2018 - Targeted acquisitions and collaborations have played a pivotal role in shaping Surmodics intravascular product solution strategy.Surmodics is focused on advancing its drug-coated balloon portfolio in
Mar 09, 2018 - Key announcements include the failure of Dermira's (DERM) acne candidate in two pivotal late-stage studies and Merck's oncology collaboration with Japan's Eisai.
Mar 09, 2018 - Big pharma companies are using their savings in tax to boost shareholders' wealth through dividends or share buybacks, ignoring consumers.
Mar 08, 2018 - Redmile Group, LLC Buys Celgene Corp, Abbott Laboratories, bluebird bio Inc, Sells Seattle Genetics Inc, Aetna Inc, GW Pharmaceuticals PLC, Stocks: TFX,UNH,CTLT,FATE,CLVS,IMGN,CELG,ABT,BLUE,WCG,MDRX, release date:Mar 08, 2018
Mar 07, 2018 - Dividend Reinvestment Plans - or DRIPs for short - are excellent options for investors who want to create a growing stream of dividend income over time. DRIPs are especially powerful when combined wit
Mar 07, 2018 - Steven Cohen Takes Stake in Biotech Company Agenus, Stocks: AGEN,REGN,MYL,MDT,VRTX,ABT, release date:Mar 07, 2018